MIRLET7F2: A Potential Drug Target and Biomarker (G406889)

Target Name: MIRLET7F2

NCBI ID: G406889

MIRLET7F2: A Potential Drug Target and Biomarker

MIRLET7F2, a protein encoded by the gene Let-7F2, is a potential drug target and biomarker associated with various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its function and regulation have been extensively studied, providing insights into the underlying mechanisms of these conditions.

The Let-7F2 gene is part of the HOMER-D gene family, which encodes a family of transmembrane proteins involved in intracellular signaling. The HOMER-D genes are known to play a crucial role in regulating various cellular processes, including cell signaling, intracellular signaling, and cell adhesion. MIRLET7F2 is a 21-kDa protein that is predominantly expressed in the brain and nervous system, with smaller amounts detected in other tissues.

MIRLET7F2 is involved in multiple cellular processes, including cell signaling, neurotransmitter release, and intracellular signaling. Its function in these processes has been extensively investigated, providing insights into the underlying mechanisms of various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

One of the most significant functions of MIRLET7F2 is its role in neurotransmitter release. MIRLET7F2 is involved in the release of several neurotransmitters, including dopamine, serotonin, and nitric oxide. These neurotransmitters play crucial roles in neural communication and are involved in various physiological processes, including mood regulation, learning, and memory. MIRLET7F2 dysfunction has been implicated in the development and progression of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

MIRLET7F2 is also involved in intracellular signaling. Its functions in intracellular signaling include the regulation of ion channels, tyrosination, and phosphorylation. MIRLET7F2 has been shown to play a role in the regulation of synaptic plasticity, a critical component of neural development and function.

In addition to its role in neurotransmitter release and intracellular signaling, MIRLET7F2 is also involved in cell adhesion and cell signaling. Its functions in these processes include the regulation of cell adhesion, as well as the regulation of cell signaling. MIRLET7F2 has been shown to play a role in the regulation of neural stem cell proliferation and differentiation.

Given the extensive research on MIRLET7F2 and its functions, it is a promising drug target and biomarker for a variety of neurodegenerative disorders. The potential therapeutic approaches for MIRLET7F2targeting may include small molecules, antibodies, or other biotherapies that can modulate its activity. For example, inhibition of MIRLET7F2 has been shown to improve neurotransmitter release and improve synaptic plasticity in animal models of neurodegenerative disorders.

In conclusion, MIRLET7F2 is a protein that is involved in multiple cellular processes, including neurotransmitter release, intracellular signaling, and cell adhesion. Its functions have been extensively studied in the context of various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Given its potential as a drug target and biomarker, MIRLET7F2 is an attractive target for the development of new therapies for these disorders.

Protein Name: MicroRNA Let-7f-2

More Common Targets